Cellogen Therapeutics raises $2.3M (India, May 2026)
$2.3M
Rs 20 croreGenerated social card
Headline
Cellogen Therapeutics raises Rs 20 crore from Kotak Alts to advance CAR-T cancer therapies - Indian Startup News
About
Cellogen Therapeutics is an Indian biotech startup that develops cell and gene therapies using Chimeric Antigen Receptor T-cell (CAR-T) technology to treat cancers and blood disorders. The company aims to make advanced therapies more accessible and affordable, addressing the high costs associated with existing CAR-T treatments.
Article summary
Cellogen Therapeutics raises Rs 20 crore from Kotak Alts to advance CAR-T cancer therapies Indian Startup News
Founder
Gaurav Kharya
Co-Founder
Investors · 1
Kotak Alternate Asset ManagersLead
FUND
Related rounds
| Jul 02, 2026 | Age Care Labs | $9.0M | Series B | India |
| Jul 02, 2026 | Startup | $300.0M | — | India |
| Jul 01, 2026 | Finkurve Financial Services Limited | $6.0M | Debt | India |
| Jul 01, 2026 | Oolka | $15.6M | Series A | India |